ATE76099T1 - Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia- viren, die sich in cho-zellen vermehren koennen. - Google Patents
Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia- viren, die sich in cho-zellen vermehren koennen.Info
- Publication number
- ATE76099T1 ATE76099T1 AT87402104T AT87402104T ATE76099T1 AT E76099 T1 ATE76099 T1 AT E76099T1 AT 87402104 T AT87402104 T AT 87402104T AT 87402104 T AT87402104 T AT 87402104T AT E76099 T1 ATE76099 T1 AT E76099T1
- Authority
- AT
- Austria
- Prior art keywords
- recombinant
- cho cells
- vectors
- dna sequence
- programming
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 title abstract 2
- 239000013598 vector Substances 0.000 title abstract 2
- 241000700618 Vaccinia virus Species 0.000 title 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 abstract 2
- 241000700626 Cowpox virus Species 0.000 abstract 1
- 108010008038 Synthetic Vaccines Proteins 0.000 abstract 1
- 229940124551 recombinant vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8613272A FR2604183B1 (fr) | 1986-09-23 | 1986-09-23 | Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho |
| EP87402104A EP0262043B1 (de) | 1986-09-23 | 1987-09-21 | DNS-Sequenz, Vektoren, rekombinante Viren und Verfahren zur Verwendung rekombinanter Vaccinia-Viren, die sich in CHO-Zellen vermehren können |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE76099T1 true ATE76099T1 (de) | 1992-05-15 |
Family
ID=9339184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87402104T ATE76099T1 (de) | 1986-09-23 | 1987-09-21 | Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia- viren, die sich in cho-zellen vermehren koennen. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5830688A (de) |
| EP (1) | EP0262043B1 (de) |
| JP (2) | JP2683804B2 (de) |
| AT (1) | ATE76099T1 (de) |
| AU (1) | AU598859B2 (de) |
| CA (1) | CA1341242C (de) |
| DE (1) | DE3779032D1 (de) |
| DK (1) | DK498387A (de) |
| FR (1) | FR2604183B1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7767449B1 (en) | 1981-12-24 | 2010-08-03 | Health Research Incorporated | Methods using modified vaccinia virus |
| US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
| US5364773A (en) * | 1991-03-07 | 1994-11-15 | Virogenetics Corporation | Genetically engineered vaccine strain |
| JPH03505523A (ja) * | 1988-06-10 | 1991-12-05 | アプライド・バイオテクノロジー・インコーポレーテッド | 組換え痘瘡ウイルスの選択方法 |
| US5225336A (en) * | 1989-03-08 | 1993-07-06 | Health Research Incorporated | Recombinant poxvirus host range selection system |
| CH682669A5 (fr) * | 1989-03-08 | 1993-10-29 | Health Research Inc | Virus recombinant modifié pour exprimer un produit de gènes chez un hôte, procédés et vaccin correspondants. |
| US6514502B1 (en) | 1999-01-26 | 2003-02-04 | Schering-Plough Veterinary Corporation | Propagation of bovine cononavirus in chinese hamster ovary cells |
| CN106255758B (zh) | 2013-11-01 | 2020-06-23 | 赛门蒂斯有限公司 | 病毒载体制造 |
| WO2024003346A1 (en) | 2022-06-30 | 2024-01-04 | Bavarian Nordic A/S | Mammalian cell line for the production of modified vaccinia virus ankara (mva) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4769330A (en) * | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
| WO1984002077A1 (en) * | 1982-11-30 | 1984-06-07 | Us Health | Process for producing poxvirus recombinants for expression of foreign genes |
| EP0162782B1 (de) * | 1984-05-22 | 1990-03-07 | Transgene S.A. | Expressionsvektoren für Faktor IX und Aktionsfaktor IX produzierende Zellinien |
-
1986
- 1986-09-23 FR FR8613272A patent/FR2604183B1/fr not_active Expired
-
1987
- 1987-09-21 DE DE8787402104T patent/DE3779032D1/de not_active Expired - Fee Related
- 1987-09-21 EP EP87402104A patent/EP0262043B1/de not_active Expired - Lifetime
- 1987-09-21 AT AT87402104T patent/ATE76099T1/de not_active IP Right Cessation
- 1987-09-22 DK DK498387A patent/DK498387A/da not_active Application Discontinuation
- 1987-09-22 CA CA000547520A patent/CA1341242C/fr not_active Expired - Fee Related
- 1987-09-23 AU AU78906/87A patent/AU598859B2/en not_active Ceased
- 1987-09-24 JP JP62240585A patent/JP2683804B2/ja not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/478,092 patent/US5830688A/en not_active Expired - Fee Related
-
1996
- 1996-09-18 JP JP8245970A patent/JP2818836B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2683804B2 (ja) | 1997-12-03 |
| JP2818836B2 (ja) | 1998-10-30 |
| FR2604183B1 (fr) | 1988-12-30 |
| JPS63157988A (ja) | 1988-06-30 |
| AU7890687A (en) | 1988-05-19 |
| US5830688A (en) | 1998-11-03 |
| DE3779032D1 (de) | 1992-06-17 |
| CA1341242C (fr) | 2001-06-05 |
| EP0262043A1 (de) | 1988-03-30 |
| DK498387D0 (da) | 1987-09-22 |
| FR2604183A1 (fr) | 1988-03-25 |
| JPH09206084A (ja) | 1997-08-12 |
| AU598859B2 (en) | 1990-07-05 |
| EP0262043B1 (de) | 1992-05-13 |
| DK498387A (da) | 1988-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE97164T1 (de) | Rekombinantes vaccinia-virus mva. | |
| DE3382837T2 (de) | Herstellung von funktionellen, menschlichen Urokinaseproteinen | |
| ATE366314T1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
| ATE169673T1 (de) | Rekombiniertes alzheimer amyloid-protein | |
| DK179290A (da) | Rekombinante cmv-neutraliserende proteiner | |
| DE68927025D1 (de) | HIV-2-Virusvarianten | |
| ATE76099T1 (de) | Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia- viren, die sich in cho-zellen vermehren koennen. | |
| AU580059B2 (en) | Vaccine against rabies and preparation process thereof | |
| NO177863C (no) | Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer | |
| DE3789525T2 (de) | Das F-Protein vom AIDS-Virus enthaltender Impfstoff. | |
| DE3787121T2 (de) | Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen. | |
| DE69019260T2 (de) | Gibbon Leukemia Virus-Rezeptor. | |
| ATE61818T1 (de) | Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparumantigenen. | |
| ATE62019T1 (de) | Verfahren zur herstellung von hcmvglykoproteinen, antikoerper dagegen und hcmvvakzine und dazu zu verwendende rekombinante vektoren. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |